BIT
NNVC icon

BlackRock Institutional Trust’s NanoViricides NNVC Stock Holding History

BlackRock Institutional Trust’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-18,100
Closed -$814K – 3942
2015
Q1 		$814K Sell
18,100
-22
-0.1% -$1.17K ﹤0.01% 3400
2014
Q4 		$986K Sell
18,122
-64
-0.4% -$4.24K ﹤0.01% 3358
2014
Q3 		$1.09M Buy
18,186
+914
+5% +$71.8K ﹤0.01% 3294
2014
Q2 		$1.46M Buy
+17,272
New +$1.23M ﹤0.01% 3313

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock Institutional Trust's NNVC Position: Q2 2015 in Review

BlackRock Institutional Trust sold out of NanoViricides (NNVC) in Q2 2015, closing a stake of 18,100 shares — an estimated $814K sold.

BlackRock Institutional Trust first reported a position in NNVC in Q2 2014 and held it in 4 quarters. The position peaked at $1.46M in Q2 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2015.

  • BlackRock Institutional Trust reported no remaining NanoViricides position as of Q2 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 18,100 NanoViricides shares in Q2 2015, an estimated $814K.
  • BlackRock Institutional Trust first reported a position in NanoViricides in Q2 2014 and held it in 4 quarters.
  • BlackRock Institutional Trust's NanoViricides position peaked at $1.46M in Q2 2014.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2015.

Based on BlackRock Institutional Trust's 13F filing for Q2 2015, filed 7 Aug 2015.